Log in to save to my catalogue

Omadacycline use in a traveler with severe Legionella pneumonia

Omadacycline use in a traveler with severe Legionella pneumonia

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e1f7bc0a3b144ff894c259a89ec365ab

Omadacycline use in a traveler with severe Legionella pneumonia

About this item

Full title

Omadacycline use in a traveler with severe Legionella pneumonia

Publisher

Netherlands: Elsevier Ltd

Journal title

Travel medicine and infectious disease, 2023-11, Vol.56, p.102654-102654, Article 102654

Language

English

Formats

Publication information

Publisher

Netherlands: Elsevier Ltd

More information

Scope and Contents

Contents

Additionally, choosing appropriate antimicrobial agents for the treatment of Legionella infections is complicated by the unreliability of antimicrobial susceptibility testing methods and the intracellular nature of the bacterium [2]. The objective of our case study was to investigate the effectiveness of omadacycline in treating Legionella pneumoni...

Alternative Titles

Full title

Omadacycline use in a traveler with severe Legionella pneumonia

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_e1f7bc0a3b144ff894c259a89ec365ab

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e1f7bc0a3b144ff894c259a89ec365ab

Other Identifiers

ISSN

1477-8939

E-ISSN

1873-0442

DOI

10.1016/j.tmaid.2023.102654

How to access this item